These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3497202)

  • 1. Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins.
    Zarling JM; Eichberg JW; Moran PA; McClure J; Sridhar P; Hu SL
    J Immunol; 1987 Aug; 139(4):988-90. PubMed ID: 3497202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus.
    Michel F; Hoffenbach A; Langlade-Demoyen P; Guy B; Girard M; Lecocq JP; Wain-Hobson S; Kieny MP; Plata F
    Eur J Immunol; 1988 Dec; 18(12):1917-24. PubMed ID: 2905993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant.
    Earl PL; Moss B; Morrison RP; Wehrly K; Nishio J; Chesebro B
    Science; 1986 Nov; 234(4777):728-31. PubMed ID: 3490689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses.
    Van Eendenburg JP; Yagello M; Girard M; Kieny MP; Lecocq JP; Muchmore E; Fultz PN; Riviere Y; Montagnier L; Gluckman JC
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):41-50. PubMed ID: 2470398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans.
    Berzofsky JA; Bensussan A; Cease KB; Bourge JF; Cheynier R; Lurhuma Z; Salaün JJ; Gallo RC; Shearer GM; Zagury D
    Nature; 1988 Aug; 334(6184):706-8. PubMed ID: 2457809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.
    Hu SL; Fultz PN; McClure HM; Eichberg JW; Thomas EK; Zarling J; Singhal MC; Kosowski SG; Swenson RB; Anderson DC
    Nature; 1987 Aug 20-26; 328(6132):721-3. PubMed ID: 3475581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses.
    Zarling JM; Morton W; Moran PA; McClure J; Kosowski SG; Hu SL
    Nature; 1986 Sep 25-Oct 1; 323(6086):344-6. PubMed ID: 3093891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to human immunodeficiency virus 1 infection of SCID mice reconstituted with peripheral blood leukocytes from donors vaccinated with vaccinia gp160 and recombinant gp160.
    Mosier DE; Gulizia RJ; MacIsaac PD; Corey L; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2443-7. PubMed ID: 8460155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.
    Perales MA; Schwartz DH; Fabry JA; Lieberman J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):27-35. PubMed ID: 7648281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.
    Cooney EL; McElrath MJ; Corey L; Hu SL; Collier AC; Arditti D; Hoffman M; Coombs RW; Smith GE; Greenberg PD
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1882-6. PubMed ID: 8446603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120.
    Berman PW; Groopman JE; Gregory T; Clapham PR; Weiss RA; Ferriani R; Riddle L; Shimasaki C; Lucas C; Lasky LA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5200-4. PubMed ID: 2455898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T cell and neutralizing antibody responses to human immunodeficiency virus type 1 envelope with a combination vaccine regimen. AIDS Vaccine Evaluation Group.
    Corey L; McElrath MJ; Weinhold K; Matthews T; Stablein D; Graham B; Keefer M; Schwartz D; Gorse G
    J Infect Dis; 1998 Feb; 177(2):301-9. PubMed ID: 9466515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
    Belyakov IM; Wyatt LS; Ahlers JD; Earl P; Pendleton CD; Kelsall BL; Strober W; Moss B; Berzofsky JA
    J Virol; 1998 Oct; 72(10):8264-72. PubMed ID: 9733870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human class I MHC-restricted cytotoxic T-lymphocytes specific for human immunodeficiency virus envelope antigens.
    Shepp DH; Daguillard F; Mann D; Quinnan GV
    AIDS; 1988 Apr; 2(2):113-7. PubMed ID: 2454643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both immunization with protein and recombinant vaccinia virus can stimulate CTL specific for the E7 protein of human papilloma virus 16 in H-2d mice.
    Zhu X; Tommasino M; Vousden K; Sadovnikava E; Rappuoli R; Crawford L; Kast M; Melief CJ; Beverley PC; Stauss HJ
    Scand J Immunol; 1995 Nov; 42(5):557-63. PubMed ID: 7481562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques.
    Earl PL; Robert-Guroff M; Matthews TJ; Krohn K; London WT; Moss B
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):23-32. PubMed ID: 2541747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees.
    Eichberg JW; Zarling JM; Alter HJ; Levy JA; Berman PW; Gregory T; Lasky LA; McClure J; Cobb KE; Moran PA
    J Virol; 1987 Dec; 61(12):3804-8. PubMed ID: 3500328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants.
    Gonzalo RM; Rodríguez D; García-Sastre A; Rodríguez JR; Palese P; Esteban M
    Vaccine; 1999 Feb; 17(7-8):887-92. PubMed ID: 10067695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation in chimpanzees of vaccinia virus recombinants that express the surface glycoproteins of human respiratory syncytial virus.
    Collins PL; Purcell RH; London WT; Lawrence LA; Chanock RM; Murphy BR
    Vaccine; 1990 Apr; 8(2):164-8. PubMed ID: 2336876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.